HSP70 multi-functionality in cancer
Z Albakova, GA Armeev, LM Kanevskiy, EI Kovalenko… - Cells, 2020 - mdpi.com
The 70-kDa heat shock proteins (HSP70s) are abundantly present in cancer, providing
malignant cells selective advantage by suppressing multiple apoptotic pathways, regulating …
malignant cells selective advantage by suppressing multiple apoptotic pathways, regulating …
[HTML][HTML] HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation
ED Mellins, LJ Stern - Current opinion in immunology, 2014 - Elsevier
Highlights•Two recent crystal structures show how DM interacts with MHCII proteins.•Studies
of H2-O knockout mice reveal a role for DO in regulating immunity and autoimmunity.•Key …
of H2-O knockout mice reveal a role for DO in regulating immunity and autoimmunity.•Key …
Susceptibility to HLA-DM protein is determined by a dynamic conformation of major histocompatibility complex class II molecule bound with peptide
L Yin, P Trenh, A Guce, M Wieczorek, S Lange… - Journal of Biological …, 2014 - ASBMB
HLA-DM mediates the exchange of peptides loaded onto MHCII molecules during antigen
presentation by a mechanism that remains unclear and controversial. Here, we investigated …
presentation by a mechanism that remains unclear and controversial. Here, we investigated …
An immunoinformatic approach to assessing the immunogenic capacity of alpha-neurotoxins in elapid snake venoms
Introduction: Most elapid snakes produce venoms that contain alpha-neurotoxins (α-NTXs),
which are proteins that cause post-synaptic blockade and paralysis in snakebite …
which are proteins that cause post-synaptic blockade and paralysis in snakebite …
HLA-DMA polymorphisms differentially affect MHC class II peptide loading
M Alvaro-Benito, M Wieczorek, J Sticht… - The Journal of …, 2015 - journals.aai.org
During the adaptive immune response, MHCII proteins display antigenic peptides on the cell
surface of APCs for CD4+ T cell surveillance. HLA-DM, a nonclassical MHCII protein, acts as …
surface of APCs for CD4+ T cell surveillance. HLA-DM, a nonclassical MHCII protein, acts as …
Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications
S Afridi, DC Hoessli, MW Hameed - Immunological Reviews, 2016 - Wiley Online Library
Major histocompatibility complex (MHC) class II molecules are expressed by antigen‐
presenting cells and stimulate CD 4+ T cells, which initiate humoral immune responses …
presenting cells and stimulate CD 4+ T cells, which initiate humoral immune responses …
Impact of HLA-DR antigen binding cleft rigidity on T cell recognition
The interaction between T cell receptor (TCR) and peptide (p)-Human Leukocyte Antigen
(HLA) complexes is the critical first step in determining T cell responses. X-ray …
(HLA) complexes is the critical first step in determining T cell responses. X-ray …
Immunoinformatics-Driven Strategies for Advancing Epitope-Based Vaccine Design for West Nile Virus
Abstract The West Nile virus (WNV) is the causative agent of West Nile disease (WND),
which poses a potential risk of meningitis or encephalitis. The aim of the study was to design …
which poses a potential risk of meningitis or encephalitis. The aim of the study was to design …
The MHC class II cofactor HLA-DM interacts with Ig in B cells
H Macmillan, MJ Strohman, S Ayyangar… - The Journal of …, 2014 - journals.aai.org
B cells internalize extracellular Ag into endosomes using the Ig component of the BCR. In
endosomes, Ag-derived peptides are loaded onto MHC class II proteins. How these …
endosomes, Ag-derived peptides are loaded onto MHC class II proteins. How these …
HLA-DM catalytically enhances peptide dissociation by sensing peptide–MHC class II interactions throughout the peptide-binding cleft
E Reyes-Vargas, AP Barker, Z Zhou, X He… - Journal of Biological …, 2020 - ASBMB
Human leukocyte antigen-DM (HLA-DM) is an integral component of the major
histocompatibility complex class II (MHCII) antigen-processing and-presentation pathway …
histocompatibility complex class II (MHCII) antigen-processing and-presentation pathway …